<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27336895</article-id>
      <article-id pub-id-type="pmc">4998333</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000003962</article-id>
      <article-id pub-id-type="art-access-id">03962</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>6900</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pyogenic arthritis of native joints due to <italic>Bacteroides fragilis</italic></article-title>
        <subtitle>Case report and review of the literature</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nolla</surname>
            <given-names>Joan M.</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>&#x2217;</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Murillo</surname>
            <given-names>Oscar</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Narvaez</surname>
            <given-names>Javier</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vaquero</surname>
            <given-names>Carmen G&#xF3;mez</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lora-Tamayo</surname>
            <given-names>Jaime</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pedrero</surname>
            <given-names>Salvador</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cabo</surname>
            <given-names>Javier</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ariza</surname>
            <given-names>Javier</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Louthrenoo.</surname>
            <given-names>Worawit</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Rheumatology Department, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain</aff>
      <aff id="aff2"><label>b</label>Infectious Diseases Department, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain</aff>
      <aff id="aff3"><label>c</label>Orthopedic Surgery Department, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain.</aff>
      <author-notes id="cor1">
        <corresp><label>&#x2217;</label>Correspondence: Joan M. Nolla, Rheumatology Department, Hospital Universitari de Bellvitge, Feixa LLarga s/n, 08907 L&#x2019;Hospitalet de LLobregat, Barcelona, Spain (e-mail: <email>jmnolla@ub.edu</email>).</corresp>
        <corresp>Abbreviations: ESR = erythrocyte sedimentation rate, WBC = white blood cell count.</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>25</issue>
      <elocation-id>e3962</elocation-id>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>5</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>5</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e3962.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>Pyogenic arthritis of native joints due to <italic>Bacteroides fragilis</italic> seems to be an infrequent disease. We analyzed the cases diagnosed in a tertiary hospital during a 22-year period and reviewed the literature to summarize the experience with this infectious entity.</p>
        <p>In our institution, of 308 patients with pyogenic arthritis of native joints, <italic>B fragilis</italic> was the causative organism in 2 (0.6%) cases. A MEDLINE search (1981&#x2013;2015) identified 19 additional cases.</p>
        <p>Of the 21 patients available for review (13 men and 8 women, with a mean age, of 54.4&#x200A;&#xB1;&#x200A;17 years), 19 (90%) presented a systemic predisposing factor for infection; the most common associated illness was rheumatoid arthritis (8 patients). Bacteremia was documented in 65% (13/20) of cases. In 5 patients (24%), 1 or more concomitant infectious process was found. Metronidazole was the most frequently used antibiotic. Surgical drainage was performed in 11 cases (52%). The overall mortality rate was 5%.</p>
        <p>Pyogenic arthritis of native joints due to <italic>B fragilis</italic> is an infrequent disease that mainly affects elderly patients with underlying medical illnesses and in whom bacteremia and the presence of a concomitant infectious process are frequent conditions.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>anaerobe</kwd>
        <kwd>
          <italic>Bacteroides fragilis</italic>
        </kwd>
        <kwd>infectious arthritis</kwd>
        <kwd>pyogenic arthritis</kwd>
        <kwd>rheumatoid arthritis</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <label>1</label>
      <title>Introduction</title>
      <p>Pyogenic arthritis presents 2 different scenarios<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> depending on whether the infection compromises prosthetic or native joints. The 2 processes have important distinctive clinical and microbiological features and require different approaches.</p>
      <p>Pyogenic arthritis of native joints<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> is a potentially life-threatening disease that can lead to rapid joint destruction and irreversible loss of function. It remains a serious medical emergency with high morbidity and mortality. A large number of gram-positive and gram-negative bacteria have been identified as causative agents.<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref>]</sup> Overall, <italic>Stahylococcus aureus</italic> has been the most commonly isolated microorganism, accounting for more than 50% of reported cases; streptococci cause almost 25% of cases and gram-negative bacilli around 10% to 15%. Anaerobic etiological agents are extremely rare; in a recent review<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> of 3-decade trends in the distribution of organisms causing septic arthritis in native joints, anaerobic bacteria caused only 2 of the 374 cases reported.</p>
      <p><italic>Bacteroides fragilis</italic> is an obligate anaerobe, a gram-negative rod that forms a part of the normal flora of the oral cavity, the skin, and the genitourinary and gastrointestinal tract. Like other microorganisms of the genre <italic>Fusobacterium, Porphyromonas, Prevotella</italic>, and <italic>Peptostreptococcus</italic> it is a nonspore forming bacteria.</p>
      <p><italic>B fragilis</italic> can become an opportunistic pathogen. In fact, it is the most commonly isolated organism in anaerobic infections and responsible for a wide spectrum of clinical manifestations. The commonest entities<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup> are primary bacteremia, periodontal disease, skin and soft tissue infections, and intra-abdominal abscesses. Other relevant but less frequent conditions are respiratory tract infections,<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> endocarditis,<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup> pericarditis,<sup>[<xref rid="R8" ref-type="bibr">8</xref>]</sup> meningitis,<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup> and osteoarticular infections.<sup>[<xref rid="R10" ref-type="bibr">10</xref>&#x2013;<xref rid="R12" ref-type="bibr">12</xref>]</sup></p>
      <p>The prevalence of <italic>B fragilis</italic> arthritis of native joints has not been established, but it seems to be an extremely rare disease. At the modern era, Ziment et al<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup> performed the first detailed description of a case in 1969. Additionally, 4 new cases<sup>[<xref rid="R14" ref-type="bibr">14</xref>&#x2013;<xref rid="R17" ref-type="bibr">17</xref>]</sup> were reported in the following decade, demonstrating the capacity of this organism to cause pyogenic arthritis. In 1990, Rosenkranz et al<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup> presented their experience, reviewed the literature, and established the state of the art about this topic.</p>
      <p>In the current study, we present the cases of pyogenic arthritis of native joints due to <italic>B fragilis</italic> observed at our institution over 2 decades, and review the available literature to summarize the experience with this infectious entity and to clarify, in the light of the current knowledge, certain clinical, and therapeutic issues of the disease.</p>
    </sec>
    <sec>
      <label>2</label>
      <title>Patients and methods</title>
      <p>We searched the database of our hospital (a 700-bed tertiary care teaching institution in Barcelona that does not treat pediatric, obstetric, or burn patients) for subjects with infectious arthritis admitted from January 1992 to December 2013.</p>
      <p>For the present study, we excluded: patients with prosthetic joint infection, patients with postoperative arthritis (patients who had undergone joint surgery or arthroscopy in the year before diagnosis), patients with arthritis secondary to traumatic or spontaneous skin or soft tissue ulcers (e.g., diabetic foot), and patients with mycobacterial, brucellar, or fungal arthritis.</p>
      <p>Three hundred eight patients [203 male (66%), 105 (34%) female; mean age: 57.7&#x200A;&#xB1;&#x200A;16.3 years] with pyogenic arthritis of native joints were identified. All cases were microbiologically proven. According to our protocol, joint fluid samples are sent directly to the laboratory, processed in liquid (thioglicolate) and solid media (5% sheep blood, chocolate, and MacConkey agar), and incubated for at least 7 days. Blood samples are cultured following standard recommendations in bottles of BacT (Bactec NR-860-system, Johnson Laboratories, Towson, MD) with both aerobic and anaerobic media. Microorganisms and their antibiotic susceptibility are identified using the MicroScan system (Dad Behring, West Sacramento, CA).</p>
      <p>Two patients with <italic>B fragilis</italic> arthritis were observed at our center during the assessment period.</p>
      <p>Previously published cases of <italic>B fragilis</italic> pyogenic arthritis of native joints were identified using a computerized search of the MEDLINE (National Library of Medicine, Bethseda, MD) database from January 1981 to December 2015. The key words used were &#x201C;<italic>Bacteroides fragilis&#x201D;</italic> and &#x201C;arthritis.&#x201D; Only reports in English, French, and Spanish were considered; the references studies obtained were then examined to identify additional reports. Only cases that were sufficiently detailed to be analyzed individually were included.</p>
      <p>We excluded: patients under the age of 18, cases of prosthetic joint infection<sup>[<xref rid="R18" ref-type="bibr">18</xref>&#x2013;<xref rid="R21" ref-type="bibr">21</xref>]</sup>; and cases of postoperative arthritis. A case<sup>[<xref rid="R22" ref-type="bibr">22</xref>]</sup> of polymicrobial arthritis involving <italic>B fragilis</italic> was not included.</p>
      <p>In accordance with the guidelines of our institutional ethics committee, formal approval for this study was not required. Informed consent was not obtained from the patients, but their clinical records and information were anonymized before analysis.</p>
    </sec>
    <sec>
      <label>3</label>
      <title>Results</title>
      <p>Nineteen cases of pyogenic arthritis of native joints due to <italic>B fragilis</italic> were identified in the literature.<sup>[<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R23" ref-type="bibr">23</xref>&#x2013;<xref rid="R38" ref-type="bibr">38</xref>]</sup> Thus, including the 2 patients observed at our center during the study period, 21 cases were available for review (Table <xref ref-type="table" rid="T1">1</xref>&#xA0;&#xA0;).</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Demographic, clinical, and laboratory findings, treatment and outcome in 21 cases of pyogenic arthritis of native joints due to <italic>Bacteroides fragilis</italic>.</p>
        </caption>
        <graphic xlink:href="medi-95-e3962-g001"/>
      </table-wrap>
      <table-wrap id="T2" position="float">
        <label>Table 1 (Continued)</label>
        <caption>
          <p>Demographic, clinical, and laboratory findings, treatment and outcome in 21 cases of pyogenic arthritis of native joints due to <italic>Bacteroides fragilis</italic>.</p>
        </caption>
        <graphic xlink:href="medi-95-e3962-g002"/>
      </table-wrap>
      <table-wrap id="T3" position="float">
        <label>Table 1 (Continued)</label>
        <caption>
          <p>Demographic, clinical, and laboratory findings, treatment and outcome in 21 cases of pyogenic arthritis of native joints due to <italic>Bacteroides fragilis</italic>.</p>
        </caption>
        <graphic xlink:href="medi-95-e3962-g003"/>
      </table-wrap>
      <p>Of these 21 patients, 13 (62 %) were men and 8 (38 %) women, with ages ranging from 19 to 78 years (54.4&#x200A;&#xB1;&#x200A;17 years). Nine patients (43%) were over 60 years of age.</p>
      <p>Nineteen patients (90%) presented a systemic predisposing factor for infection. The most common associated illness was rheumatoid arthritis (8 patients). Other relevant but more infrequent conditions were inflammatory diseases (systemic lupus erythematosus, mixed connective tissue disease, and psoriatic arthritis, 1 case each) and cancer (1 case of gastric adenocarcinoma with bone metastases and 1 case of non-Hodgkin lymphoma).</p>
      <p>Fifteen percent (3/20) of patients did not present with fever before diagnosis. Fifteen patients (71%) presented monoarthritis. The knee was the most frequently compromised joint (12 patients).</p>
      <p>The erythrocyte sedimentation rate (ESR) was above 50&#x200A;mm/h in all cases in whom this datum was reported. Mean ESR was 99.8&#x200A;&#xB1;&#x200A;30.7 (range: 52&#x2013;128). In 72% of patients (10/14) the white blood cell count (WBC) was above 11&#x200A;&#xD7;&#x200A;10<sup>9</sup>/L; the mean WBC was 13.2&#x200A;&#xB1;&#x200A;5.1&#x200A;&#xD7;&#x200A;10<sup>9</sup>/L (range, 5.5&#x2013;24.6). Synovial fluid cultures gave positive results in all cases in whom they were performed (20/21). Blood cultures gave positive results in the 65% of cases (13/20).</p>
      <p>Five patients (24%) presented 1 or more concomitant infectious processes due to the same microorganism. The most frequent was pyomiositis (3 patients); other entities were uterine infection, abscess after tracheostomy, and surgical wound infection.</p>
      <p>Initial empirical therapy varied among patients, whereas metronidazole was the most used antibiotic after bacterial identification. As part of the standard management, some patients underwent daily percutaneous articular drainage. Surgical debridement was performed in 11 (52%) patients.</p>
      <p>One patient (5%) presented relapse and 1 (5%) died.</p>
    </sec>
    <sec>
      <label>4</label>
      <title>Discussion</title>
      <p>Although Pasteur in one of his earliest publications described obligatory anaerobic bacteria, anaerobic infection other than that caused by certain species of clostridia received relatively little attention over the following 100 years. In 1974, Gorbach and Bartlett<sup>[<xref rid="R39" ref-type="bibr">39</xref>&#x2013;<xref rid="R41" ref-type="bibr">41</xref>]</sup> reviewed the available literature on pyogenic processes associated with anaerobic organisms of the normal flora and provided your expertise. These authors stated that anaerobic bacteria are rarely encountered in pyogenic arthritis.</p>
      <p>It is established that anaerobic arthritis mainly affects patients undergoing surgical treatment for traumatic injuries or elective musculoskeletal surgery (arthroplasty or other orthopedic devices); when it occurs, <italic>B fragilis</italic> is the principal causative microorganism.<sup>[<xref rid="R11" ref-type="bibr">11</xref>]</sup> However, information on anaerobic arthritis of native joints is very scarce.</p>
      <p>In the present study, we reviewed all cases of <italic>B fragilis</italic> pyogenic arthritis of native joints published in the literature since 1981 and included 2 patients attended at our hospital. The summarized experience, comprising 21 cases, is, by far, the largest series on this infectious disease.</p>
      <p>Data from our institution confirm that <italic>B fragilis</italic> is an exceptional causative agent of pyogenic arthritis of native joints, representing only 0.6% of all diagnosed cases. The figure obtained for overall anaerobic infection is similar to than observed in the series of adult patients with infectious arthritis published in the literature over the last decade,<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R42" ref-type="bibr">42</xref>&#x2013;<xref rid="R47" ref-type="bibr">47</xref>]</sup> with the exception of the series of Lim et al<sup>[<xref rid="R42" ref-type="bibr">42</xref>]</sup> who reported an high frequency of patients with prosthetic joint infection (21%). Nevertheless, it is possible that the failure to culture under anaerobic conditions will underestimate the real importance of <italic>B fragilis</italic> as a causative agent.</p>
      <p>Our review demonstrates that <italic>B fragilis</italic> arthritis mainly appears in elderly patients. A predominance among males was also noted as also occurs in the general series of pyogenic arthritis.<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R42" ref-type="bibr">42</xref>&#x2013;<xref rid="R47" ref-type="bibr">47</xref>]</sup></p>
      <p>The presence of concomitant chronic debilitating disease in the vast majority of patients (90%) indicates the opportunistic nature of the microorganism. Ischemic heart disease, sickle cell disease, malignancy, and above all rheumatoid arthritis (40%) were the main underlying processes.</p>
      <p>The association between <italic>B fragilis</italic> pyogenic arthritis and rheumatoid arthritis has been previously reported<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup> and should be particularly emphasized according to the data included in the present revision.</p>
      <p>Overall, patients with rheumatoid arthritis are particularly susceptible to pyogenic arthritis. The estimated incidence of this complication ranges from 0.3% to 3%.<sup>[<xref rid="R48" ref-type="bibr">48</xref>]</sup><italic>S aureus</italic> is the main etiological agent, causing more than 70% of cases. The frequency of anaerobic arthritis is low, though it seems higher than observed in the general population. In the classical review of Gardner and Weisman,<sup>[<xref rid="R49" ref-type="bibr">49</xref>]</sup> anaerobes accounted for 3% of cases (6/213) observed between 1946 and 1987. In our experience,<sup>[<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R50" ref-type="bibr">50</xref>]</sup> anaerobic bacteria were the causative agents of 6% of cases (2/35) attended between 1981 and 2013. The mechanisms responsible for the increased vulnerability to joint infection have not been precisely identified, but skin defects, previous articular damage, poor clearance of bacteria from the joint, and acquired phagocytic defects secondary to drugs or disease have been proposed.<sup>[<xref rid="R48" ref-type="bibr">48</xref>,<xref rid="R49" ref-type="bibr">49</xref>]</sup> In the particular case of <italic>B fragilis</italic> additionally is important to consider the relevant role of its capsula as a virulent factor,<sup>[<xref rid="R51" ref-type="bibr">51</xref>]</sup> promoting abscess formation by inhibiting opsonophagocytosis. Thus, the damaged joint along with the systemic immunologic impairment may be the key factors in the development of arthritis by <italic>B fragilis</italic> in patients with rheumatoid arthritis.</p>
      <p>The percentage of patients who remained afebrile before diagnosis was low, but noticeable. These cases stress the importance of maintaining a high index of suspicion of infection when 1 joint (or more) suddenly becomes inflamed, especially in immunocompromised hosts. The infection involved more than 1 joint in almost 30% of cases, whereas the classically reported frequency of polyarthritis is 15%.<sup>[<xref rid="R52" ref-type="bibr">52</xref>]</sup> As in the general series of pyogenic arthritis,<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R42" ref-type="bibr">42</xref>&#x2013;<xref rid="R47" ref-type="bibr">47</xref>]</sup> the knee was the most commonly affected joint.</p>
      <p>The high percentage of cases with positive blood cultures should also be noted; bacteremia was detected in 65% of the cases in whom blood culture results were available. Most cases of <italic>B fragilis</italic> arthritis have been attributed to hematogenous spread from a distant infected focus, usually intra-abdominal. However, on occasions this focus has not been identified despite a search strategy that includes colonoscopy and computerized tomography of the abdomen.<sup>[<xref rid="R24" ref-type="bibr">24</xref>]</sup></p>
      <p>In our review, a quarter of patients present a concomitant infectious process, mainly pyomiositis as a result of contiguous spread of the infection. This circumstance must be borne in mind since the symptoms and signs of pyogenic arthritis and pyomiositis are similar and one of them may be missed or incompletely treated.<sup>[<xref rid="R23" ref-type="bibr">23</xref>]</sup></p>
      <p>Anaerobic and aerobic arthritis require the same treatment,<sup>[<xref rid="R53" ref-type="bibr">53</xref>]</sup> comprising temporary immobilization, drainage of the joint, and adequate antibiotic therapy. Some authors<sup>[<xref rid="R31" ref-type="bibr">31</xref>]</sup> favor hyperbaric oxygen therapy as an adjunctive treatment in the management of the patients if the preservation or restoration of the blood supply in the area involved is not possible.</p>
      <p>Prompt complete removal of infected synovial fluid is necessary to preserve good joint function and to control the infection. This aids bacterial clearance from synovial fluid and tissues, rapidly decreases the intra-articular pressure, reduces cartilage damage, and increases the efficacy of antimicrobial therapy. No large prospective comparative studies are available, and the choice of drainage (repeated closed needle aspiration or surgical drainage) remains controversial.<sup>[<xref rid="R54" ref-type="bibr">54</xref>]</sup></p>
      <p>Few data are available on the antibiotic therapy of arthritis due to <italic>B fragilis</italic> and no recommendations have been clearly established. For treatment of anaerobic bacterial infections, clindamycin has classically considered the gold standard. However, <italic>B fragilis</italic> antibiotic resistance to clindamycin has increased over the years, reaching 41.8% in Mediterranean countries<sup>[<xref rid="R55" ref-type="bibr">55</xref>]</sup> and now, empirical therapy by this antibiotic should be discouraged.<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup></p>
      <p>Data from this review show that initial empirical therapy varied among patients, while metronidazole was the most used antibiotic after bacterial identification. While &#x3B2;-lactam antibiotics resistant to &#x3B2;-lactamases may be considered good alternative therapy if an appropriate articular drainage is warranted, metronidazole provides a better theoretical profile because its reported bactericidal activity in the purulent milieu of the arthritis.<sup>[<xref rid="R56" ref-type="bibr">56</xref>,<xref rid="R57" ref-type="bibr">57</xref>]</sup></p>
      <p>Relapse seems to be rare in <italic>B fragilis</italic> arthritis, being observed in only 1 of the 21 cases analyzed. The mortality rate (5%) was consistent with recently published reports<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref>]</sup> of native pyogenic arthritis. Underlying medical processes and bacteremia are the main determinants of death in patients with infectious arthritis.<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup> The difficulty of modifying these variables means that it is hard to reduce mortality rates despite advances in the medical and surgical management of these patients.</p>
      <p>In summary, <italic>B fragilis</italic> is an infrequent causative agent of pyogenic arthritis of native joints. Joint disease due to this microorganism mainly affects aged patients with underlying medical illnesses, in whom bacteremia and the presence of a concomitant infectious process are frequent conditions. Relapse seems to be uncommon and the mortality rates are consistent with those reported in native pyogenic arthritis.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>The authors have no conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Arias</surname><given-names>M</given-names></name><name><surname>Balsa</surname><given-names>A</given-names></name><name><surname>Mola</surname><given-names>EM</given-names></name></person-group>
<article-title>Septic arthritis</article-title>. <source><italic>Best Pract Res Clin Rheumatol</italic></source>
<year>2011</year>; <volume>25</volume>:<fpage>407</fpage>&#x2013;<lpage>421</lpage>.<pub-id pub-id-type="pmid">22100289</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname><given-names>CJ</given-names></name><name><surname>Weston</surname><given-names>VC</given-names></name><name><surname>Jones</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Bacterial septic arthritis in adults</article-title>. <source><italic>Lancet</italic></source>
<year>2010</year>; <volume>375</volume>:<fpage>846</fpage>&#x2013;<lpage>855</lpage>.<pub-id pub-id-type="pmid">20206778</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubost</surname><given-names>JJ</given-names></name><name><surname>Couderc</surname><given-names>M</given-names></name><name><surname>Tatar</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>Three-decade trends in the distribution of organisms causing septic arthritis in native joints: single-center study of 374 cases</article-title>. <source><italic>Joint Bone Spine</italic></source>
<year>2014</year>; <volume>81</volume>:<fpage>438</fpage>&#x2013;<lpage>440</lpage>.<pub-id pub-id-type="pmid">24956987</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolla</surname><given-names>JM</given-names></name><name><surname>Lora-Tamayo</surname><given-names>J</given-names></name><name><surname>G&#xF3;mez Vaquero</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Pyogenic arthritis of native joints in non intravenous drug users: a detailed analysis of 268 cases attended in a tertiary hospital over a 22 year period</article-title>. <source><italic>Semin Arthritis Rheum</italic></source>
<year>2015</year>; <volume>45</volume>:<fpage>94</fpage>&#x2013;<lpage>102</lpage>.<pub-id pub-id-type="pmid">25767047</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papaparaskevas</surname><given-names>J</given-names></name><name><surname>Katsandri</surname><given-names>A</given-names></name><name><surname>Pantazatou</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Epidemiological characteristics of infections caused by Bacteroides, Prevotella and Fusobacterium species: a prospective observational study</article-title>. <source><italic>Anaerobe</italic></source>
<year>2011</year>; <volume>17</volume>:<fpage>113</fpage>&#x2013;<lpage>117</lpage>.<pub-id pub-id-type="pmid">21664284</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartlett</surname><given-names>JG</given-names></name></person-group>
<article-title>Anaerobic bacterial infections of the lung and pleural space</article-title>. <source><italic>Clin Infect Dis</italic></source>
<year>1993</year>; <volume>16</volume>
<issue>suppl 4</issue>:<fpage>S248</fpage>&#x2013;<lpage>S255</lpage>.<pub-id pub-id-type="pmid">8324127</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I</given-names></name></person-group>
<article-title>Infective endocarditis caused by anaerobic bacteria</article-title>. <source><italic>Arch Cardiovasc Dis</italic></source>
<year>2008</year>; <volume>101</volume>:<fpage>665</fpage>&#x2013;<lpage>676</lpage>.<pub-id pub-id-type="pmid">19056073</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I</given-names></name></person-group>
<article-title>Pericarditis caused by anaerobic bacteria</article-title>. <source><italic>Int J Antimicrob Agents</italic></source>
<year>2009</year>; <volume>33</volume>:<fpage>297</fpage>&#x2013;<lpage>300</lpage>.<pub-id pub-id-type="pmid">18789852</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feder</surname><given-names>HM</given-names><suffix>Jr</suffix></name></person-group>
<article-title>Bacteroides fragilis meningitis</article-title>. <source><italic>Rev Infect Dis</italic></source>
<year>1987</year>; <volume>9</volume>:<fpage>783</fpage>&#x2013;<lpage>786</lpage>.<pub-id pub-id-type="pmid">3326124</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>RH</given-names><suffix>Jr</suffix></name><name><surname>Rosenblatt</surname><given-names>JE</given-names></name><name><surname>Tenney</surname><given-names>JH</given-names></name><name><surname>Bourgault</surname><given-names>AM</given-names></name></person-group>
<article-title>Anaerobic septic arthritis</article-title>. <source><italic>Clin Orthop Relat Res</italic></source>
<year>1982</year>; <volume>164</volume>:<fpage>141</fpage>&#x2013;<lpage>148</lpage>.<pub-id pub-id-type="pmid">6121642</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I</given-names></name><name><surname>Frazier</surname><given-names>EH</given-names></name></person-group>
<article-title>Anaerobic osteomyelitis and arthritis in a military hospital: a 10-year experience</article-title>. <source><italic>Am J Med</italic></source>
<year>1993</year>; <volume>94</volume>:<fpage>21</fpage>&#x2013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">8420297</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>G</given-names></name><name><surname>Vernier</surname><given-names>M</given-names></name><name><surname>Pinelli</surname><given-names>PO</given-names></name><etal/></person-group>
<article-title>Bone and joint infections due to anaerobic bacteria: an analysis of 61 cases and review of the literature</article-title>. <source><italic>Eur J Clin Microbiol Infect Dis</italic></source>
<year>2014</year>; <volume>33</volume>:<fpage>1355</fpage>&#x2013;<lpage>1364</lpage>.<pub-id pub-id-type="pmid">24577953</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziment</surname><given-names>I</given-names></name><name><surname>Davis</surname><given-names>A</given-names></name><name><surname>Finegold</surname><given-names>SM</given-names></name></person-group>
<article-title>Joint infection by anaerobic bacteria: a case report and review of the literature</article-title>. <source><italic>Arthritis Rheum</italic></source>
<year>1969</year>; <volume>12</volume>:<fpage>627</fpage>&#x2013;<lpage>635</lpage>.<pub-id pub-id-type="pmid">4903326</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brorson</surname><given-names>JE</given-names></name><name><surname>Edmar</surname><given-names>G</given-names></name><name><surname>Holm</surname><given-names>SE</given-names></name></person-group>
<article-title>Some clinical, immunological and bacteriological observations in a case of pyogenic arthritis due to bacteroides fragilis</article-title>. <source><italic>Scand J Infect Dis</italic></source>
<year>1975</year>; <volume>7</volume>:<fpage>222</fpage>&#x2013;<lpage>224</lpage>.<pub-id pub-id-type="pmid">1179177</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayer</surname><given-names>AS</given-names></name><name><surname>Chow</surname><given-names>AW</given-names></name><name><surname>Louie</surname><given-names>JS</given-names></name><name><surname>Guze</surname><given-names>LB</given-names></name></person-group>
<article-title>Sternoarticular pyoarthrosis due to gram-negative bacilli. Report of eight cases</article-title>. <source><italic>Arch Intern Med</italic></source>
<year>1997</year>; <volume>137</volume>:<fpage>1036</fpage>&#x2013;<lpage>1040</lpage>.<pub-id pub-id-type="pmid">879941</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rye&#xE9;n</surname><given-names>AC</given-names></name><name><surname>Schean</surname><given-names>A</given-names></name><name><surname>Agell</surname><given-names>BO</given-names></name></person-group>
<article-title>A case of septic arthritis in multiple joints due to <italic>Bacteroides fragilis</italic> in a patient with rheumatoid arthritis</article-title>. <source><italic>Acta Orthop Scand</italic></source>
<year>1978</year>; <volume>49</volume>:<fpage>98</fpage>&#x2013;<lpage>101</lpage>.<pub-id pub-id-type="pmid">654904</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Childers</surname><given-names>JC</given-names></name></person-group>
<article-title>Pyogenic arthritis due to bacteroides fragilis infection</article-title>. <source><italic>Orthopedics</italic></source>
<year>1980</year>; <volume>3</volume>:<fpage>319</fpage>&#x2013;<lpage>320</lpage>.<pub-id pub-id-type="pmid">24822590</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenkranz</surname><given-names>P</given-names></name><name><surname>Lederman</surname><given-names>MM</given-names></name><name><surname>Gopalakrishna</surname><given-names>KV</given-names></name><name><surname>Ellner</surname><given-names>JJ</given-names></name></person-group>
<article-title>Septic arthritis caused by Bacteroides fragilis</article-title>. <source><italic>Rev Infect Dis</italic></source>
<year>1990</year>; <volume>12</volume>:<fpage>20</fpage>&#x2013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">2405467</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>KL</given-names></name><name><surname>Kaplowitz</surname><given-names>LG</given-names></name></person-group>
<article-title>Late infection with Bacteroides fragilis in a prosthetic joint</article-title>. <source><italic>Scand J Infect Dis</italic></source>
<year>1980</year>; <volume>12</volume>:<fpage>235</fpage>.<pub-id pub-id-type="pmid">7433924</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickey</surname><given-names>MM</given-names></name><name><surname>Davies</surname><given-names>UM</given-names></name><name><surname>Dave</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Metronidazole resistant Bacteroides fragilis infection of a prosthetic hip joint</article-title>. <source><italic>J Infect</italic></source>
<year>1990</year>; <volume>20</volume>:<fpage>129</fpage>&#x2013;<lpage>133</lpage>.<pub-id pub-id-type="pmid">2319145</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>SH</given-names></name><name><surname>Yang</surname><given-names>RS</given-names></name><name><surname>Tsai</surname><given-names>CL</given-names></name></person-group>
<article-title>Septic arthritis of the hip joint in cervical cancer patients after radiotherapy: three case reports</article-title>. <source><italic>J Orthop Surg (Hong Kong)</italic></source>
<year>2001</year>; <volume>9</volume>:<fpage>41</fpage>&#x2013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">12118130</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikolich</surname><given-names>PJ</given-names></name><name><surname>Schlaeffer</surname><given-names>F</given-names></name><name><surname>Ryter</surname><given-names>RJ</given-names></name></person-group>
<article-title>Polymicrobial polyarticular arthritis</article-title>. <source><italic>J Rheumatol</italic></source>
<year>1994</year>; <volume>21</volume>:<fpage>971</fpage>&#x2013;<lpage>972</lpage>.<pub-id pub-id-type="pmid">8064749</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papanikolaou</surname><given-names>A</given-names></name><name><surname>Tzavara</surname><given-names>V</given-names></name><name><surname>Chini</surname><given-names>M</given-names></name><name><surname>Papatheodorou</surname><given-names>A</given-names></name></person-group>
<article-title>Pyomyositis and septic hip arthritis due to bacteroides fragilis. A case report</article-title>. <source><italic>Hip Int</italic></source>
<year>2011</year>; <volume>21</volume>:<fpage>498</fpage>&#x2013;<lpage>501</lpage>.<pub-id pub-id-type="pmid">21786258</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>T</given-names></name><name><surname>Aziz</surname><given-names>H</given-names></name></person-group>
<article-title>Bacteroides fragilis: a case study of bacteremia and septic arthritis</article-title>. <source><italic>Clin Lab Sci</italic></source>
<year>2009</year>; <volume>22</volume>:<fpage>131</fpage>&#x2013;<lpage>135</lpage>.<pub-id pub-id-type="pmid">19827405</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luis Cousseau</surname><given-names>M</given-names></name><name><surname>Gentile</surname><given-names>J</given-names></name><name><surname>P&#xE9;rez</surname><given-names>R</given-names></name></person-group>
<article-title>Septic arthritis due to Bacteroides fragilis in a patient with non-Hodgkin lymphoma and mixed connective tissue disease</article-title>. <source><italic>Reumatol Clin</italic></source>
<year>2007</year>; <volume>3</volume>:<fpage>237</fpage>&#x2013;<lpage>240</lpage>.<pub-id pub-id-type="pmid">21794438</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nehra</surname><given-names>A</given-names></name><name><surname>Mehta</surname><given-names>RN</given-names></name><name><surname>Encarnacion</surname><given-names>C</given-names></name></person-group>
<article-title>Bacteroides fragilis arthritis in a patient with sickle cell disease</article-title>. <source><italic>Am J Med</italic></source>
<year>2001</year>; <volume>111</volume>:<fpage>161</fpage>.<pub-id pub-id-type="pmid">11501546</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolla</surname><given-names>JM</given-names></name><name><surname>Gomez Vaquero</surname><given-names>C</given-names></name><name><surname>Fiter</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Pyarthrosis in patients with rheumatoid arthritis. A detailed analysis of 10 cases and literature review</article-title>. <source><italic>Semin Arthritis Rheum</italic></source>
<year>2000</year>; <volume>30</volume>:<fpage>121</fpage>&#x2013;<lpage>126</lpage>.<pub-id pub-id-type="pmid">11071583</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borer</surname><given-names>A</given-names></name><name><surname>Weber</surname><given-names>G</given-names></name><name><surname>Riesenberg</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Septic arthritis due to bacteroides fragilis after pilonidal sinus resection in a patient with rheumatoid arthritis</article-title>. <source><italic>Clin Rheumatol</italic></source>
<year>1997</year>; <volume>16</volume>:<fpage>632</fpage>&#x2013;<lpage>634</lpage>.<pub-id pub-id-type="pmid">9456020</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Failla</surname><given-names>DM</given-names></name><name><surname>Dalovisio</surname><given-names>JR</given-names></name></person-group>
<article-title>Bacteroides fragilis arthritis following cesarean section</article-title>. <source><italic>Clin Infect Dis</italic></source>
<year>1995</year>; <volume>21</volume>:<fpage>1341</fpage>&#x2013;<lpage>1342</lpage>.<pub-id pub-id-type="pmid">8589176</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvo-Al&#xE9;n</surname><given-names>J</given-names></name><name><surname>Pinillos</surname><given-names>V</given-names></name><name><surname>del Val</surname><given-names>N</given-names></name><name><surname>Rodr&#xED;guez Valverde</surname><given-names>V</given-names></name></person-group>
<article-title>Pyomyositis and septic arthritis due to Bacteroides fragilis in an immunocompetent patient</article-title>. <source><italic>Clin Infect Dis</italic></source>
<year>1995</year>; <volume>21</volume>:<fpage>1344</fpage>.<pub-id pub-id-type="pmid">8589179</pub-id></mixed-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merle-Melet</surname><given-names>M</given-names></name><name><surname>Mainard</surname><given-names>D</given-names></name><name><surname>Regent</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>An unusual case of hip septic arthritis due to Bacteroides fragilis in an alcoholic patient</article-title>. <source><italic>Infection</italic></source>
<year>1994</year>; <volume>22</volume>:<fpage>353</fpage>&#x2013;<lpage>355</lpage>.<pub-id pub-id-type="pmid">7843815</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konstantopoulos</surname><given-names>K</given-names></name><name><surname>Avlami</surname><given-names>A</given-names></name><name><surname>Demarongona</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Bacteroides fragilis arthritis in a sickle cell-thalassaemia patient</article-title>. <source><italic>Scand J Infect Dis</italic></source>
<year>1994</year>; <volume>26</volume>:<fpage>495</fpage>&#x2013;<lpage>497</lpage>.<pub-id pub-id-type="pmid">7984987</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chomarat</surname><given-names>M</given-names></name><name><surname>Cahen</surname><given-names>R</given-names></name><name><surname>Durieu</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Septic arthritis caused by Bacteroides fragilis in the setting of postlithiasis pyelonephritis</article-title>. <source><italic>Clin Infect Dis</italic></source>
<year>1992</year>; <volume>15</volume>:<fpage>569</fpage>&#x2013;<lpage>570</lpage>.<pub-id pub-id-type="pmid">1520821</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawes</surname><given-names>PT</given-names></name><name><surname>Hothersall</surname><given-names>TE</given-names></name></person-group>
<article-title>Septic polyarthritis due to bacteroides fragilis in a patient with rheumatoid arthritis</article-title>. <source><italic>Clin Rheumatol</italic></source>
<year>1984</year>; <volume>3</volume>:<fpage>381</fpage>&#x2013;<lpage>383</lpage>.<pub-id pub-id-type="pmid">6488717</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dodd</surname><given-names>MJ</given-names></name><name><surname>Griffiths</surname><given-names>ID</given-names></name><name><surname>Freeman</surname><given-names>R</given-names></name></person-group>
<article-title>Pyogenic arthritis due to bacteroides complicating rheumatoid arthritis</article-title>. <source><italic>Ann Rheum Dis</italic></source>
<year>1982</year>; <volume>41</volume>:<fpage>248</fpage>&#x2013;<lpage>249</lpage>.<pub-id pub-id-type="pmid">6124215</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>CA</given-names></name><name><surname>Godfrey</surname><given-names>VM</given-names></name><name><surname>Woodrow</surname><given-names>JC</given-names></name><name><surname>Percival</surname><given-names>A</given-names></name></person-group>
<article-title>Septic arthritis due to Bacteroides fragilis in a wrist affected by rheumatoid arthritis</article-title>. <source><italic>Ann Rheum Dis</italic></source>
<year>1982</year>; <volume>41</volume>:<fpage>623</fpage>&#x2013;<lpage>624</lpage>.<pub-id pub-id-type="pmid">7149802</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schorn</surname><given-names>D</given-names></name><name><surname>Pretorius</surname><given-names>JA</given-names></name></person-group>
<article-title>Septic polyarthritis due to Bacteroides fragilis in a patient with rheumatoid arthritis. A case report</article-title>. <source><italic>S Afr Med J</italic></source>
<year>1982</year>; <volume>62</volume>:<fpage>213</fpage>&#x2013;<lpage>214</lpage>.<pub-id pub-id-type="pmid">7101073</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#xED;nez-Luengas Oribe</surname><given-names>F</given-names></name><name><surname>Montejo Baranda</surname><given-names>M</given-names></name><name><surname>Aguirre Errasti</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Septic arthritis caused by Bacteroides fragilis in a patient with rheumatoid arthritis</article-title>. <source><italic>Med Clin (Barc)</italic></source>
<year>1982</year>; <volume>78</volume>:<fpage>65</fpage>&#x2013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">7070132</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorbach</surname><given-names>SL</given-names></name><name><surname>Bartlett</surname><given-names>JG</given-names></name></person-group>
<article-title>Anaerobic infections</article-title>. <source><italic>N Engl J Med</italic></source>
<year>1974</year>; <volume>290</volume>:<fpage>1177</fpage>&#x2013;<lpage>1184</lpage>.<pub-id pub-id-type="pmid">4824012</pub-id></mixed-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorbach</surname><given-names>SL</given-names></name><name><surname>Bartlett</surname><given-names>JG</given-names></name></person-group>
<article-title>Anaerobic infections (second of three parts)</article-title>. <source><italic>N Engl J Med</italic></source>
<year>1974</year>; <volume>290</volume>:<fpage>1237</fpage>&#x2013;<lpage>1245</lpage>.<pub-id pub-id-type="pmid">4596718</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorbach</surname><given-names>SL</given-names></name><name><surname>Bartlett</surname><given-names>JG</given-names></name></person-group>
<article-title>Anaerobic infections (third of three parts)</article-title>. <source><italic>N Engl J Med</italic></source>
<year>1974</year>; <volume>290</volume>:<fpage>1289</fpage>&#x2013;<lpage>1294</lpage>.<pub-id pub-id-type="pmid">4597253</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>SY</given-names></name><name><surname>Pannikath</surname><given-names>D</given-names></name><name><surname>Nugent</surname><given-names>K</given-names></name></person-group>
<article-title>A retrospective study of septic arthritis in a tertiary hospital in West Texas with high rates of methicillin-resistant Staphylococcus aureus infection</article-title>. <source><italic>Rheumatol Int</italic></source>
<year>2015</year>; <volume>35</volume>:<fpage>1251</fpage>&#x2013;<lpage>1256</lpage>.<pub-id pub-id-type="pmid">25572838</pub-id></mixed-citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maneiro</surname><given-names>JR</given-names></name><name><surname>Souto</surname><given-names>A</given-names></name><name><surname>Cervantes</surname><given-names>EC</given-names></name><etal/></person-group>
<article-title>Predictors of treatment failure and mortality in native septic arthritis</article-title>. <source><italic>Clin Rheumtol</italic></source>
<year>2015</year>; <volume>34</volume>:<fpage>1961</fpage>&#x2013;<lpage>1967</lpage>.</mixed-citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madruga Dias</surname><given-names>J</given-names></name><name><surname>Costa</surname><given-names>MM</given-names></name><name><surname>Pereira da Silva</surname><given-names>JA</given-names></name><name><surname>Viana de Queiroz</surname><given-names>M</given-names></name></person-group>
<article-title>Septic arthritis: patients with or without isolated infectious agents have similar characteristics</article-title>. <source><italic>Infection</italic></source>
<year>2014</year>; <volume>42</volume>:<fpage>385</fpage>&#x2013;<lpage>391</lpage>.<pub-id pub-id-type="pmid">24318567</pub-id></mixed-citation>
      </ref>
      <ref id="R45">
        <label>45</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu&#xF1;oz-Egea</surname><given-names>MC</given-names></name><name><surname>Blanco</surname><given-names>A</given-names></name><name><surname>Fernandez Roblas</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Clinical and microbiological characteristics of patients with septic arthritis: a hospital-based study</article-title>. <source><italic>J Orthopaedics</italic></source>
<year>2014</year>; <volume>11</volume>:<fpage>87</fpage>&#x2013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">25104892</pub-id></mixed-citation>
      </ref>
      <ref id="R46">
        <label>46</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>FY</given-names></name><name><surname>Abu-Khattab</surname><given-names>M</given-names></name><name><surname>Baagar</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Characteristics of patients with definite septic arthritis at Hamad General Hospital, Qatar: a hospital-based study from 2006 to 2011</article-title>. <source><italic>Clin Rheumatol</italic></source>
<year>2013</year>; <volume>32</volume>:<fpage>969</fpage>&#x2013;<lpage>973</lpage>.<pub-id pub-id-type="pmid">23404237</pub-id></mixed-citation>
      </ref>
      <ref id="R47">
        <label>47</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clerc</surname><given-names>O</given-names></name><name><surname>Prod&#x2019;hom</surname><given-names>G</given-names></name><name><surname>Greub</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Adult native septic arthritis: a review of 10 years of experience and lessons for empirical antibiotic therapy</article-title>. <source><italic>J Antimicrob Chemother</italic></source>
<year>2011</year>; <volume>6</volume>:<fpage>1168</fpage>&#x2013;<lpage>1173</lpage>.<pub-id pub-id-type="pmid">21393124</pub-id></mixed-citation>
      </ref>
      <ref id="R48">
        <label>48</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldenberg</surname><given-names>DL</given-names></name></person-group>
<article-title>Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders</article-title>. <source><italic>Arthritis Rheum</italic></source>
<year>1989</year>; <volume>32</volume>:<fpage>496</fpage>&#x2013;<lpage>502</lpage>.<pub-id pub-id-type="pmid">2650687</pub-id></mixed-citation>
      </ref>
      <ref id="R49">
        <label>49</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>GC</given-names></name><name><surname>Weisman</surname><given-names>MH</given-names></name></person-group>
<article-title>Pyarthrosis in patients with rheumatoid arthritis: a report of 13 cases and a review of the literature from the past 40 years</article-title>. <source><italic>Am J Med</italic></source>
<year>1990</year>; <volume>88</volume>:<fpage>503</fpage>&#x2013;<lpage>511</lpage>.<pub-id pub-id-type="pmid">2186625</pub-id></mixed-citation>
      </ref>
      <ref id="R50">
        <label>50</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateo Soria</surname><given-names>L</given-names></name><name><surname>Nolla Sol&#xE9;</surname><given-names>JM</given-names></name><name><surname>Rozadilla Sacanell</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Infectious arthritis in patients with rheumatoid arthritis</article-title>. <source><italic>Ann Rheum Dis</italic></source>
<year>1992</year>; <volume>51</volume>:<fpage>402</fpage>&#x2013;<lpage>403</lpage>.<pub-id pub-id-type="pmid">1575593</pub-id></mixed-citation>
      </ref>
      <ref id="R51">
        <label>51</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onderdonk</surname><given-names>AB</given-names></name><name><surname>Kasper</surname><given-names>DL</given-names></name><name><surname>Cisneros</surname><given-names>RL</given-names></name><name><surname>Bartlett</surname><given-names>JG</given-names></name></person-group>
<article-title>The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains</article-title>. <source><italic>J Infect Dis</italic></source>
<year>1977</year>; <volume>136</volume>:<fpage>82</fpage>&#x2013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">886206</pub-id></mixed-citation>
      </ref>
      <ref id="R52">
        <label>52</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubost</surname><given-names>JJ</given-names></name><name><surname>Fis</surname><given-names>I</given-names></name><name><surname>Denis</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Polyarticular septic arthritis</article-title>. <source><italic>Medicine (Baltimore)</italic></source>
<year>1993</year>; <volume>72</volume>:<fpage>296</fpage>&#x2013;<lpage>310</lpage>.<pub-id pub-id-type="pmid">8412643</pub-id></mixed-citation>
      </ref>
      <ref id="R53">
        <label>53</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I</given-names></name></person-group>
<article-title>Microbiology and management of joint and bone infections due to anaerobic bacteria</article-title>. <source><italic>J Orthop Sci</italic></source>
<year>2008</year>; <volume>13</volume>:<fpage>160</fpage>&#x2013;<lpage>169</lpage>.<pub-id pub-id-type="pmid">18392922</pub-id></mixed-citation>
      </ref>
      <ref id="R54">
        <label>54</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname><given-names>CJ</given-names></name><name><surname>Kingsley</surname><given-names>G</given-names></name><name><surname>Field</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Management of septic arthritis: a systematic review</article-title>. <source><italic>Ann Rheum Dis</italic></source>
<year>2007</year>; <volume>66</volume>:<fpage>440</fpage>&#x2013;<lpage>445</lpage>.<pub-id pub-id-type="pmid">17223664</pub-id></mixed-citation>
      </ref>
      <ref id="R55">
        <label>55</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>E</given-names></name><name><surname>Urb&#xE1;n</surname><given-names>E</given-names></name><name><surname>Nord</surname><given-names>CE</given-names></name></person-group>
<collab>ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria</collab>. <article-title>Antimicrobial susceptibility of Bacteroides fragilis Group isolates in Europe: 20 years of experience</article-title>. <source><italic>Clin Microbiol Infect</italic></source>
<year>2011</year>; <volume>17</volume>:<fpage>371</fpage>&#x2013;<lpage>379</lpage>.<pub-id pub-id-type="pmid">20456453</pub-id></mixed-citation>
      </ref>
      <ref id="R56">
        <label>56</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tally</surname><given-names>FP</given-names></name></person-group>
<article-title>Factors affecting antimicrobial agents in an anaerobic abscess</article-title>. <source><italic>J Antimicrob Chemother</italic></source>
<year>1978</year>; <volume>4</volume>:<fpage>299</fpage>&#x2013;<lpage>302</lpage>.<pub-id pub-id-type="pmid">308504</pub-id></mixed-citation>
      </ref>
      <ref id="R57">
        <label>57</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>CD</given-names></name><name><surname>Klutman</surname><given-names>NE</given-names></name><name><surname>Lamp</surname><given-names>KC</given-names></name></person-group>
<article-title>Metronidazole. A therapeutic review and update</article-title>. <source><italic>Drugs</italic></source>
<year>1997</year>; <volume>54</volume>:<fpage>679</fpage>&#x2013;<lpage>708</lpage>.<pub-id pub-id-type="pmid">9360057</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
